menu
    • menu

    Company profile for Scribe Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Scribe TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1150 Marina Village Pkwy, Alameda, CA 94501, US
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.scribetx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/scribe-therapeutics/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Scribe Eyes Clinic As CRISPR Candidates Lower Lipids In Animals
    Scribe Eyes Clinic As CRISPR Candidates Lower Lipids In Animals

    17 Nov 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/research/scribe-outlines-clinical-plans-after-crispr-candidates-lower-lipids-animals

    FIERCE BIOTECH
    17 Nov 2025
    Share Share
    Scribe Showcases Lp(a)-Lowering Therapy & AI CRISPR Platform
    Scribe Showcases Lp(a)-Lowering Therapy & AI CRISPR Platform

    09 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-09/scribe-therapeutics-highlights-latest-data-on-lp-a-lowering-therapy-and-novel-ai-platform-for-next

    PHARMAWEB
    09 Sep 2025
    Share Share
    Scribe Therapeutics Showcases Leadership in Science and Business
    Scribe Therapeutics Showcases Leadership in Science and Business

    25 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-25/scribe-therapeutics-to-demonstrate-scientific-and-corporate-leadership-at-upcoming-conferences

    PHARMAWEB
    25 Aug 2025
    Share Share
    Scribe Therapeutics Reports Positive Preclinical Data on Novel CR
    Scribe Therapeutics Reports Positive Preclinical Data on Novel CR

    22 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250522194036/en/Scribe-Therapeutics-Reports-Positive-Preclinical-Data-on-its-Novel-CRISPR-Technologies-at-the-2025-EAS-Congress-and-ASGCT-Annual-Meeting

    BUSINESSWIRE
    22 May 2025
    Share Share
    Scribe to Present Crispr Based Data for Duchenne Muscular Dystrophy
    Scribe to Present Crispr Based Data for Duchenne Muscular Dystrophy

    05 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250505857479/en/Scribe-Therapeutics-to-Highlight-In-Vivo-CRISPR-based-Genome-Editing-Data-for-Duchenne-Muscular-Dystrophy-at-ASGCT-2025-in-Addition-to-Joint-Presentation-with-Prevail-Therapeutics-a-Part-of-Lillys-Gene-Therapy-Division

    BUSINESSWIRE
    05 May 2025
    Share Share
    Scribe, Prevail to Present In Vivo AAV Tech at ASGCT
    Scribe, Prevail to Present In Vivo AAV Tech at ASGCT

    28 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250428937434/en/Scribe-Achieves-Milestone-for-In-Vivo-Program-in-Collaboration-with-Prevail-Therapeutics-a-part-of-Lillys-Gene-Therapy-Division-and-Announces-ASGCT-Joint-Presentation-on-Self-Inactivating-AAV-Technology-for-Neurological-and-Neuromuscular-Disorders

    BUSINESSWIRE
    28 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search